Home › Funds › Patient Square Capital LP › UTHR

Patient Square Capital LP position in UTHR

UNITED THERAPEUTICS CORP DEL · Health Care

Patient Square Capital LP reported holding 62,677 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$34.0M, representing 5.42% of its reported portfolio and ranking #3 among its reported holdings. Patient Square Capital LP has disclosed UTHR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)62.68K sh
Reported value held$33.96M
Portfolio Weight5.42%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's UTHR position evolved

Patient Square Capital LP first disclosed a stake in UTHR in Q2 2026 at 37,120 shares (US$20.1M). The position peaked in Q3 2026 at 62,677 shares, worth US$34.0M. Across 2 filings, Patient Square Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 62,677 shares valued at US$34.0M — an increase of 25,557 shares quarter over quarter.. Notable position changes include a 69% increase in Q3 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 37.12K $20.11M New
Q3 2026 62.68K $33.96M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UTHR and 13F data

UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UTHR

All UTHR fund holders →

FAQ

How long has Patient Square Capital LP held UTHR?

Patient Square Capital LP has disclosed UTHR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Patient Square Capital LP's current position in UTHR?

As of Q3 2026, Patient Square Capital LP holds 62.68K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $33.96M, representing 5.42% of its reported portfolio and ranking #3.

Has Patient Square Capital LP been buying or selling UTHR?

In the latest 13F filing (Q3 2026), Patient Square Capital LP increased its position in UTHR. The position peaked in Q3 2026 at 62.68K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.